0001415889-22-007540.txt : 20220707
0001415889-22-007540.hdr.sgml : 20220707
20220707172718
ACCESSION NUMBER: 0001415889-22-007540
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220706
FILED AS OF DATE: 20220707
DATE AS OF CHANGE: 20220707
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kirby John J.
CENTRAL INDEX KEY: 0001556327
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31918
FILM NUMBER: 221072376
MAIL ADDRESS:
STREET 1: C/O IDERA PHARMACEUTICALS, INC.
STREET 2: 505 EAGLEVIEW BLVD., SUITE 212
CITY: EXTON
STATE: PA
ZIP: 19341
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IDERA PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000861838
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 043072298
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 505 EAGLEVIEW BOULEVARD
STREET 2: SUITE 212
CITY: EXTON
STATE: PA
ZIP: 19341
BUSINESS PHONE: 4843481600
MAIL ADDRESS:
STREET 1: 505 EAGLEVIEW BOULEVARD
STREET 2: SUITE 212
CITY: EXTON
STATE: PA
ZIP: 19341
FORMER COMPANY:
FORMER CONFORMED NAME: HYBRIDON INC
DATE OF NAME CHANGE: 19951211
4
1
form4-07072022_020708.xml
X0306
4
2022-07-06
0000861838
IDERA PHARMACEUTICALS, INC.
IDRA
0001556327
Kirby John J.
C/O IDERA PHARMACEUTICALS, INC.
505 EAGLEVIEW BOULEVARD, SUITE 212
EXTON
PA
19341
false
true
false
false
CHIEF FINANCIAL OFFICER
Stock Option (Right to Buy)
0.4327
2022-07-06
4
A
0
66500
0
A
2032-07-06
Common Stock
66500
66500
D
The stock option award was granted under the Issuer's 2013 Stock Incentive Plan. The stock option will vest and become exercisable in full on July 6, 2026, with 25% vesting on July 6, 2023, and the remainder vesting in twelve equal quarterly installments over the remaining three years, subject to continued service with the Issuer.
/s/ John J. Kirby
2022-07-07